Abstract
NF-κB transcription factor is activated upon ubiquitination and subsequent proteolysis of its inhibitor IκB. The phosphorylation-dependent ubiquitination is mediated by SCF E3 ubiquitin ligase. In this study, we identified a novel murine F-box/WD40 repeat-containing protein, mHOS (a homologue of HOS/βTrCP2). mHOS efficiently binds Skp1 protein (a ‘core’ component of SCF ubiquitin ligase), and phosphorylated IκBα. We found that mHOS associates with SCF-ROC1 E3 ubiquitin ligase activity. We have also observed that mHOS is overexpressed in chemically-induced mouse skin tumors, and its overexpression (but not accelerated IκB phosphorylation) coincides with the accelerated degradation of IκB in vivo. The role of mHOS in the constitutive activation of NF-κB in skin carcinogenesis is discussed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Baeuerle PA, Baichwal VR . 1997 Adv. Immunol. 65: 111–137
Baichwal VR, Baeuerle PA . 1997 Curr. Biol. 7: R94–96
Barnes PJ, Karin M . 1997 N. Engl. J. Med. 336: 1066–1071
Budunova IV, Perez P, Vaden VR, Spiegelman VS, Slaga TJ, Jorcano JL . 1999 Oncogene 18: 7423–7431
Deshaies RJ . 1999 Annu. Rev. Cell Dev. Biol. 15: 435–467
DiGiovanni J, Beltran L, Rupp A, Harvey RG, Gill RD . 1993 Mol. Carcinog. 8: 272–279
Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ, Baldwin Jr AS . 1997 J. Biol. Chem. 272: 24113–24116
Fuchs SY, Chen A, Xiong Y, Pan ZQ, Ronai Z . 1999 Oncogene 18: 2039–2046
Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, Perret C, Rubinfeld B, Margottin F, Benarous R, Polakis P . 1999 Curr. Biol. 9: 207–210
Hatakeyama S, Kitagawa M, Nakayama K, Shirane M, Matsumoto M, Hattori K, Higashi H, Nakano H, Okumura K, Onoe K, Good RA, Nakayama K . 1999 Proc. Natl. Acad. Sci. USA 96: 3859–3863
Jiang J, Struhl G . 1998 Nature 391: 493–496
Jo H, Zhang R, Zhang H, McKinsey TA, Shao J, Beauchamp RD, Ballard DW, Liang P . 2000 Oncogene 19: 841–849
Kitagawa M, Hatgakeyama S, Shirane M, Matsumoto M, Ishida N, Hattori K, Nakamichi I, Kikuchi A, Nakayama K . 1999 EMBO J. 18: 2401–2410
Kroll M, Margottin F, Kohl A, Renard P, Durand H, Concordet JP, Bachelerie F, Arenzana-Seisdedos F, Benarous R . 1999 J. Biol. Chem. 274: 7941–7945
LaCasse EC, Baird S, Korneluk RG, MacKenzie AE . 1998 Oncogene 17: 3247–3259
Latres E, Chiaur DS, Pagano M . 1999 Oncogene 18: 849–854
Liu C, Kato Y, Zhang Z, Do VM, Yankner BA, He X . 1999 Proc. Natl. Acad. Sci. USA 96: 6273–6278
Margottin F, Bour SP, Durand H, Selig L, Benichou S, Richard V, Thomas D, Strebel K, Benarous R . 1998 Mol. Cell 1: 565–574
Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ, Baldwin Jr AS . 1997 Science 278: 1812–1815
Pelling JC, Ernst SM, Strawhecker JM, Johnson JA, Nairn RS, Slaga TJ . 1986 Carcinogenesis 7: 1599–1602
Pelling JC, Fischer SM, Neades R, Strawhecker J, Schweickert L . 1987 Carcinogenesis 8: 1481–1484
Pelling JC, Neades R, Strawhecker J . 1988 Carcinogenesis 9: 665–667
Rodriguez-Puebla ML, LaCava M, Bolontrade MF, Russell J, Conti CJ . 1999 Mol. Carcinog. 26: 150–156
Siebenlist U, Franzoso G, Brown K . 1994 Annu. Rev. Cell Biol. 10: 405–455
Soldatenkov VA, Dritschilo A, Ronai Z, Fuchs SY . 1999 Cancer Res. 59: 5085–5088
Sonenshein GE . 1997 Semin. Cancer Biol. 8: 113–119
Spencer E, Jiang J, Chen ZJ . 1999 Genes Dev. 13: 284–294
Spiegelman VS, Slaga TJ, Pagano M, Minamoto T, Ronai Z, Fuchs SY . 2000 Mol. Cell 5: 877–882
Spiegelman VS, Stavropoulos P, Latres E, Pagano M, Ronai Z, Slaga TJ, Fuchs SY . 2001 J. Biol. Chem. 276: 27152–27158
Suzuki H, Kobayashi M, Takeuchi M, Furuichi K, Chiba T, Tanaka K . 1999 FEBS Lett. 458: 343–348
Tan P, Fuchs SY, Chen A, Wu K, Gomez C, Ronai Z, Pan ZQ . 1999 Mol. Cell 3: 527–533
Verma IM, Stevenson J . 1997 Proc. Natl. Acad. Sci. USA 94: 11758–11760
Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, Harper JW . 1999 Genes Dev. 13: 270–283
Wu K, Fuchs SY, Chen A, Tan P, Gomez C, Ronai Z, Pan ZQ . 2000 Mol. Cell Biol. 20: 1382–1393
Xu Y, Bialik S, Jones BE, Iimuro Y, Kitsis RN, Srinivasan A, Brenner DA, Czaja MJ . 1998 Am. J. Physiol. 275: C1058–1066
Yaron A, Gonen H, Alkalay I, Hatzubai A, Jung S, Beyth S, Mercurio F, Manning AM, Ciechanover A, Ben-Neriah Y . 1997 EMBO J. 16: 6486–6494
Yaron A, Hatzubai A, Davis M, Lavon I, Amit S, Manning AM, Andersen JS, Mann M, Mercurio F, Ben-Neriah Y . 1998 Nature 396: 590–594
Zhang XY, Safah H, Mudad R, Maher E, Krause J, Miller A, Ehrlich M . 1997 Am. J. Hematol. 55: 205–207
Acknowledgements
We thank Drs V Fried, D Ballard, R Deshaies, and M Karin, for their generous gifts of reagents. We thank Dr R Strange for the critical suggestions and Dr K Spiegelman for help with the manuscript preparation. The study was supported by NIH grants CA 76262 (to TJ Slaga) and CA 92900 (to SY Fuchs).
Author information
Authors and Affiliations
Corresponding author
Additional information
The coding sequence of mHOS has been deposited in GenBank database (accession number AY038079).
Rights and permissions
About this article
Cite this article
Bhatia, N., Herter, J., Slaga, T. et al. Mouse homologue of HOS (mHOS) is overexpressed in skin tumors and implicated in constitutive activation of NF-κB. Oncogene 21, 1501–1509 (2002). https://doi.org/10.1038/sj.onc.1205311
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205311
Keywords
This article is cited by
-
Intrathyroid thymic carcinoma: clinicopathological features and whole exome sequencing analysis
Virchows Archiv (2023)
-
The functional analysis of Cullin 7 E3 ubiquitin ligases in cancer
Oncogenesis (2020)
-
The long noncoding RNA PCGEM1 promotes cell proliferation, migration and invasion via targeting the miR-182/FBXW11 axis in cervical cancer
Cancer Cell International (2019)
-
Fbxw11 promotes the proliferation of lymphocytic leukemia cells through the concomitant activation of NF-κB and β-catenin/TCF signaling pathways
Cell Death & Disease (2018)
-
RIPK4 activity in keratinocytes is controlled by the SCFβ-TrCP ubiquitin ligase to maintain cortical actin organization
Cellular and Molecular Life Sciences (2018)